Lixte Biotechnology Holdings Inc (LIXT)
2.338
+0.01
(+0.35%)
USD |
NASDAQ |
May 31, 16:00
2.32
-0.02
(-0.77%)
After-Hours: 20:00
Lixte Biotechnology Holdings Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
iBio Inc | -- |
PAVmed Inc | -0.6621 |
PDS Biotechnology Corp | -- |
Moleculin Biotech Inc | -- |
Syros Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 3.589M |
Total Liabilities (Quarterly) | 0.4628M |
Shareholders Equity (Quarterly) | 3.126M |